4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-24-038470
Director sold 23,000 shares at $3.57 ($82,110)
- Director acquired 23,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Patrick Kristin · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-23 | Exercise or conversion : show line 1 in the form | +3,000 | $1.64 | $4,920 | 3,000 | D |
| 2024-08-23 | Exercise or conversion : show line 2 in the form | +20,000 | $1.67 | $33,400 | 23,000 | D |
| 2024-08-23 | Sale : show line 3 in the form | −23,000 | $3.57 | $82,110 | 0 | D |
| Open-market sales · 23,000 sh · avg $3.57 · $82,110 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-23 | Exercise or conversion : show line 4 in the form Stock Option (right to buy) | −3,000 | 17,000 | D |
| 2024-08-23 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −20,000 | 0 | D |
Loading xslF345X05/wk-form4_1724713582.xml…